IL-4 inhibits the TNF-alpha induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-alpha to induce apoptotic and cytokine responses by RCC: implications for antitumor immune responses.

Claudia Falkensammer; Karin Jöhrer; Hubert Gander; Reinhold Ramoner; Thomas Putz; Andrea Rahm; Richard Greil; Georg Bartsch; Martin Thurnher

doi:10.1007/s00262-006-0122-1

IL-4 inhibits the TNF-alpha induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-alpha to induce apoptotic and cytokine responses by RCC: implications for antitumor immune responses.

Claudia Falkensammer, Karin Jöhrer, Hubert Gander, Reinhold Ramoner, Thomas Putz, Andrea Rahm, Richard Greil (Co-author), Georg Bartsch, Martin Thurnher

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article › peer-review

32 Citations (Web of Science)

Original language	English
Pages (from-to)	1228-1237
Journal	CANCER IMMUNOLOGY, IMMUNOTHERAPY : CII
Volume	55
Issue number	10
DOIs	https://doi.org/10.1007/s00262-006-0122-1
Publication status	Published - 2006

Keywords

RECOMBINANT HUMAN INTERLEUKIN-4
SOUTHWEST-ONCOLOGY-GROUP
CYTOTOXIC T-LYMPHOCYTES
PHASE-II TRIAL
DENDRITIC CELLS
IN-VITRO
MALIGNANT-MELANOMA
GROWTH-FACTOR
EXPRESSION
EOTAXIN

Access to Document

10.1007/s00262-006-0122-1

Cite this

Falkensammer, C., Jöhrer, K., Gander, H., Ramoner, R., Putz, T., Rahm, A., Greil, R., Bartsch, G., & Thurnher, M. (2006). IL-4 inhibits the TNF-alpha induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-alpha to induce apoptotic and cytokine responses by RCC: implications for antitumor immune responses. CANCER IMMUNOLOGY, IMMUNOTHERAPY : CII, 55(10), 1228-1237. https://doi.org/10.1007/s00262-006-0122-1

@article{80b6574018e4488abb78b4f58a66a33f,

title = "IL-4 inhibits the TNF-alpha induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-alpha to induce apoptotic and cytokine responses by RCC: implications for antitumor immune responses.",

keywords = "RECOMBINANT HUMAN INTERLEUKIN-4, SOUTHWEST-ONCOLOGY-GROUP, CYTOTOXIC T-LYMPHOCYTES, PHASE-II TRIAL, DENDRITIC CELLS, IN-VITRO, MALIGNANT-MELANOMA, GROWTH-FACTOR, EXPRESSION, EOTAXIN",

author = "Claudia Falkensammer and Karin J{\"o}hrer and Hubert Gander and Reinhold Ramoner and Thomas Putz and Andrea Rahm and Richard Greil and Georg Bartsch and Martin Thurnher",

year = "2006",

doi = "10.1007/s00262-006-0122-1",

language = "English",

volume = "55",

pages = "1228--1237",

journal = "CANCER IMMUNOLOGY, IMMUNOTHERAPY : CII",

issn = "0340-7004",

publisher = "Springer Verlag",

number = "10",

}

Falkensammer, C, Jöhrer, K, Gander, H, Ramoner, R, Putz, T, Rahm, A, Greil, R, Bartsch, G & Thurnher, M 2006, 'IL-4 inhibits the TNF-alpha induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-alpha to induce apoptotic and cytokine responses by RCC: implications for antitumor immune responses.', CANCER IMMUNOLOGY, IMMUNOTHERAPY : CII, vol. 55, no. 10, pp. 1228-1237. https://doi.org/10.1007/s00262-006-0122-1

IL-4 inhibits the TNF-alpha induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-alpha to induce apoptotic and cytokine responses by RCC: implications for antitumor immune responses. / Falkensammer, Claudia; Jöhrer, Karin; Gander, Hubert et al.
In: CANCER IMMUNOLOGY, IMMUNOTHERAPY : CII, Vol. 55, No. 10, 2006, p. 1228-1237.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - IL-4 inhibits the TNF-alpha induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-alpha to induce apoptotic and cytokine responses by RCC: implications for antitumor immune responses.

AU - Falkensammer, Claudia

AU - Jöhrer, Karin

AU - Gander, Hubert

AU - Ramoner, Reinhold

AU - Putz, Thomas

AU - Rahm, Andrea

AU - Greil, Richard

AU - Bartsch, Georg

AU - Thurnher, Martin

PY - 2006

Y1 - 2006

KW - RECOMBINANT HUMAN INTERLEUKIN-4

KW - SOUTHWEST-ONCOLOGY-GROUP

KW - CYTOTOXIC T-LYMPHOCYTES

KW - PHASE-II TRIAL

KW - DENDRITIC CELLS

KW - IN-VITRO

KW - MALIGNANT-MELANOMA

KW - GROWTH-FACTOR

KW - EXPRESSION

KW - EOTAXIN

U2 - 10.1007/s00262-006-0122-1

DO - 10.1007/s00262-006-0122-1

M3 - Original Article

C2 - 16810557

SN - 0340-7004

VL - 55

SP - 1228

EP - 1237

JO - CANCER IMMUNOLOGY, IMMUNOTHERAPY : CII

JF - CANCER IMMUNOLOGY, IMMUNOTHERAPY : CII

IS - 10

ER -